Skip to main content
Top
Published in: Infection 3/2011

01-06-2011 | Correspondence

Unusual presentation of Streptococcus pneumoniae-induced septic shock 36 years after splenectomy

Authors: P. Scheiermann, I. Rösch, A. G. Nerlich, R. Huf, S. N. Kunz, F. Janner, F. Weis, O. Peschel

Published in: Infection | Issue 3/2011

Login to get access

Excerpt

The lifetime risk of post-splenectomy patients to develop an overwhelming post-splenectomy infection (OPSI) with encapsulated bacteria, namely, Streptococcus pneumoniae, Haemophilus influenzae or Neisseria meningitidis is about 1–5% [1, 2]. Therefore, vaccination against those bacteria is mandatory following elective or emergency splenectomy. The recommended time frame of post-splenectomy vaccination is 2 weeks [3]. In the case of OPSI, mortality rate ranges between 40 and 70% [1], with a peak among patients with underlying haematological malignancies [4]. Despite updated guidelines describing the appropriate management of splenectomised patients [5], OPSI is still a major medical problem, with the highest incidence between 10 and 30 years after splenectomy [4]. It is of utmost importance to identify asplenic patients in case of a medical emergency. Respective alert cards could provide important information on the patient’s past history [6], which might enable early goal-directed therapy in case of an infection [7]. …
Literature
1.
go back to reference Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7:657–60.PubMedCrossRef Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7:657–60.PubMedCrossRef
2.
go back to reference Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am. 1996;10:693–707.PubMedCrossRef Lynch AM, Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am. 1996;10:693–707.PubMedCrossRef
3.
go back to reference Harji DP, Jaunoo SS, Mistry P, Nesargikar PN. Immunoprophylaxis in asplenic patients. Int J Surg. 2009;7:421–3.PubMedCrossRef Harji DP, Jaunoo SS, Mistry P, Nesargikar PN. Immunoprophylaxis in asplenic patients. Int J Surg. 2009;7:421–3.PubMedCrossRef
4.
go back to reference Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:214–8.PubMedCrossRef Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol. 2001;54:214–8.PubMedCrossRef
5.
go back to reference Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med. 2002;2:440–3.PubMed Davies JM, Barnes R, Milligan D. Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Clin Med. 2002;2:440–3.PubMed
6.
go back to reference Ong EL, Hassan IS, Snow MH. Pneumococcal sepsis in a splenectomized patient. Br J Gen Pract. 1995;45:502–3.PubMed Ong EL, Hassan IS, Snow MH. Pneumococcal sepsis in a splenectomized patient. Br J Gen Pract. 1995;45:502–3.PubMed
7.
go back to reference Engelhardt M, Haas PS, Theilacker C, Eber SW, Schmugge M, Kern WV, Heimpel H. Prevention of infections and thromboses after splenectomy or because of functional loss of the spleen. Dtsch Med Wochenschr. 2009;134:897–902.PubMedCrossRef Engelhardt M, Haas PS, Theilacker C, Eber SW, Schmugge M, Kern WV, Heimpel H. Prevention of infections and thromboses after splenectomy or because of functional loss of the spleen. Dtsch Med Wochenschr. 2009;134:897–902.PubMedCrossRef
8.
go back to reference [No authors listed]. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ. 1996;312:430–4. [No authors listed]. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. BMJ. 1996;312:430–4.
9.
go back to reference Abildgaard N, Nielsen JL. Pneumococcal septicaemia and meningitis in vaccinated splenectomized adult patients. Scand J Infect Dis. 1994;26:615–7.PubMedCrossRef Abildgaard N, Nielsen JL. Pneumococcal septicaemia and meningitis in vaccinated splenectomized adult patients. Scand J Infect Dis. 1994;26:615–7.PubMedCrossRef
10.
go back to reference Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol. 2001;4:105–21.PubMedCrossRef Hansen K, Singer DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol. 2001;4:105–21.PubMedCrossRef
11.
12.
go back to reference Mourtzoukou EG, Pappas G, Peppas G, Falagas ME. Vaccination of asplenic or hyposplenic adults. Br J Surg. 2008;95:273–80.PubMedCrossRef Mourtzoukou EG, Pappas G, Peppas G, Falagas ME. Vaccination of asplenic or hyposplenic adults. Br J Surg. 2008;95:273–80.PubMedCrossRef
13.
go back to reference Corazza GR, Tarozzi C, Vaira D, Frisoni M, Gasbarrini G. Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed). 1984;289:861–4.CrossRef Corazza GR, Tarozzi C, Vaira D, Frisoni M, Gasbarrini G. Return of splenic function after splenectomy: how much tissue is needed? Br Med J (Clin Res Ed). 1984;289:861–4.CrossRef
14.
go back to reference Tillmann W, Burow M, Schröter W. Infection prevention following splenectomy: protective effect of a new 17-valent pneumococcal vaccine. Monatsschr Kinderheilkd. 1983;131:848–52.PubMed Tillmann W, Burow M, Schröter W. Infection prevention following splenectomy: protective effect of a new 17-valent pneumococcal vaccine. Monatsschr Kinderheilkd. 1983;131:848–52.PubMed
15.
go back to reference Corbett SM, Rebuck JA, Rogers FB, Callas P, Grindlinger G, Desjardins S, Hebert JC. Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma. 2007;62:397–403.PubMedCrossRef Corbett SM, Rebuck JA, Rogers FB, Callas P, Grindlinger G, Desjardins S, Hebert JC. Time lapse and comorbidities influence patient knowledge and pursuit of medical care after traumatic splenectomy. J Trauma. 2007;62:397–403.PubMedCrossRef
16.
go back to reference Canete DR. Pacemaker product identification card for travelers. Pacing Clin Electrophysiol. 1980;3:741.PubMedCrossRef Canete DR. Pacemaker product identification card for travelers. Pacing Clin Electrophysiol. 1980;3:741.PubMedCrossRef
17.
go back to reference Kerridge RK, Crittenden MB, Vutukuri VL. A multiple-hospital anaesthetic problem register: establishment of a regionally organized system for facilitated reporting of potentially recurring anaesthetic-related problems. Anaesth Intensive Care. 2001;29:106–12.PubMed Kerridge RK, Crittenden MB, Vutukuri VL. A multiple-hospital anaesthetic problem register: establishment of a regionally organized system for facilitated reporting of potentially recurring anaesthetic-related problems. Anaesth Intensive Care. 2001;29:106–12.PubMed
Metadata
Title
Unusual presentation of Streptococcus pneumoniae-induced septic shock 36 years after splenectomy
Authors
P. Scheiermann
I. Rösch
A. G. Nerlich
R. Huf
S. N. Kunz
F. Janner
F. Weis
O. Peschel
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Infection / Issue 3/2011
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0097-5

Other articles of this Issue 3/2011

Infection 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine